Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Validation Protocol Preparation – V 2.0

Posted on By

Analytical Method Development: SOP for Validation Protocol Preparation – V 2.0

Standard Operating Procedure for Preparation of Validation Protocol in AMD


Department Analytical Method Development
SOP No. SOP/AMD/210/2025
Supersedes SOP/AMD/210/2022
Page No. Page 1 of 13
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

This SOP outlines the procedure for the preparation, review, and approval of validation protocols for analytical methods developed within the Analytical Method Development (AMD) department. It ensures that all validation studies are planned systematically and

are compliant with ICH Q2(R1), WHO, and GMP requirements.

2. Scope

This SOP applies to all analytical methods for APIs, finished products, raw materials, excipients, and cleaning procedures developed and validated in the AMD department requiring a validation protocol before method execution.

3. Responsibilities

  • Analytical Scientist: Drafts the validation protocol with all necessary details.
  • Group Leader: Reviews and finalizes the protocol before submission to QA.
  • QA Executive: Verifies compliance with validation and documentation standards.
  • Department Head: Approves the final version of the protocol for execution.
See also  Analytical Method Development: SOP for Swab Sampling Method Development - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for the accuracy, compliance, and timely approval of all validation protocols prior to execution.

5. Procedure

5.1 Structure of the Validation Protocol

  1. The validation protocol should include the following sections:
    • Title Page (Method name, validation number, product name)
    • Table of Contents
    • Objective and Scope
    • Responsibility Matrix
    • Test Parameters (e.g., specificity, linearity, accuracy, precision, robustness, LOD, LOQ)
    • Acceptance Criteria
    • Materials and Instrumentation
    • Analytical Procedure (step-by-step method summary)
    • Data Evaluation and Reporting Requirements
    • Reference Documents
    • Annexures and Templates

5.2 Preparation Process

  1. Download the latest validation protocol template (Annexure-1).
  2. Insert method-specific information and define the validation approach (full, partial, verification).
  3. Specify:
    • Number of batches or samples
    • Concentration range for linearity
    • Recovery levels for accuracy
    • Replicates for precision
    • Conditions for robustness
See also  Analytical Method Development: GC Assay Method for Volatile APIs - V 2.0

5.3 Review and Approval

  1. Submit the draft to the Group Leader for internal review.
  2. Forward the reviewed protocol to QA for compliance check.
  3. Obtain final approval from the Department Head.
  4. Store signed and approved protocol in the AMD validation archive before execution begins.

5.4 Deviation and Amendment

  1. Any changes post-approval shall be documented as a protocol amendment (Annexure-3).
  2. Deviations during validation must be recorded and justified in the final report with cross-reference to this protocol.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • LOD: Limit of Detection
  • LOQ: Limit of Quantification
  • QA: Quality Assurance
  • AMD: Analytical Method Development

7. Documents

  1. Validation Protocol Template – Annexure-1
  2. Parameter Table Format – Annexure-2
  3. Protocol Amendment Log – Annexure-3

8. References

  • ICH Q2(R1): Validation of Analytical Procedures
  • WHO Technical Report Series 996
  • GMP Guidelines – Schedule M (India)
See also  Analytical Method Development: Specific Gravity & Density Determination Method - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Nisha Rawat Anuj Kulkarni Sunita Reddy
Designation Analyst QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Validation Protocol Template

Document Code: AMD/VAL/PROT/TEMP/01

Annexure-2: Parameter Table Format

Parameter No. of Replicates Acceptance Criteria
Precision 6 RSD ≤ 2.0%
Accuracy 3 levels (80%, 100%, 120%) 95–105% recovery
Linearity 5 concentrations r² ≥ 0.990

Annexure-3: Protocol Amendment Log

Amendment No. Date Description Reason Approved By
001 20/05/2025 Added second analyst for precision QA recommendation Anuj Kulkarni

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Revised structure to align with ICH Q14 format Annual SOP Review Sunita Reddy
06/04/2022 1.0 Initial Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Use of CIP (Clean-In-Place) Systems in Injectable Manufacturing – V 2.0
Next Post: Biosimilars: SOP for Viral Inactivation via Low pH Treatment – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version